Form D · Biotechnology
DiaMedica Therapeutics Inc.
Minneapolis, MN · CIK 0001401040
Offering snapshot reported Jul 25, 2025 · SEC filing
- Reported sold
- $30.1M Offering amount: $30.1M
- Investors reported
- 14 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jul 23, 2025 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jul 25, 2025 | Initial | $30,100,000 | No comparison | 14 | SEC filing |
| Jul 2, 2024 | Initial | $11,800,000 | No comparison | 10 | SEC filing |
| Jun 27, 2023 | Initial | $37,536,853 | No comparison | 34 | SEC filing |
| Apr 18, 2023 | Initial | $750,000 | No comparison | 1 | SEC filing |
| Oct 6, 2021 | Initial | $29,999,995 | No comparison | 10 | SEC filing |
| Apr 17, 2018 | Initial | $200,870 | No comparison | 7 | SEC filing |
| May 16, 2007 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-552749
Source: Form D, filed Jul 25, 2025. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Harry W. Alcorn Jr. | Executive |
| Amy L. Burroughs | Director |
| Dominic Cundari | Executive |
| Julie Daves | Executive |
| Sydney Gilman | Executive |
| R. Michael Giuffre | Director |
| Michael R. Giuffre | Director |
| Kirsten Gruis | Executive |
| David Gurvey | Executive |
| Scott Kellen | Executive |
| Richard Kuntz | Director |
| Tanya N. Lewis | Director |
| Lorianne Masuoka | Executive |
| Daniel O'connor | Director |
| Paul Papi | Executive |
| James T. Parsons | Director |
| Rick Pauls | Director, Executive |
| Richard D. Pilnik | Director |
| Charles P. Semba | Director |
| Todd Verdoorn | Executive |
| David J. Wambeke | Executive |
| Zhenyu (Jerry) Xiao | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
301 Carlson Parkway Suite 210
Minneapolis, MN, 55305
Minneapolis, MN, 55305